ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,537Medicare Part D Prescriptions Filled, Including Refills

Rank: 22 out of 1128

$1.37M Total Retail Price of All Prescriptions

Rank: 28 out of 1128

860 Patients Receiving at Least One Drug in Part D
75% Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Tennessee
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

3% of this provider’s 860 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

17% of this provider’s 860 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
LISINOPRIL 1,169 845 186 1 4
SIMVASTATIN 972 794 152 2 2
AMLODIPINE BESYLATE 896 737 127 3 3
LEVOTHYROXINE SODIUM 836 704 132 4 1
OMEPRAZOLE 743 515 118 5 5
ALPRAZOLAM 738 586 120 B 6 12
HYDROCHLOROTHIAZIDE 723 646 115 7 14
METOPROLOL TARTRATE 613 522 111 8 10
FUROSEMIDE 575 489 119 9 7
METFORMIN HCL 549 449 104 10 9
ATORVASTATIN CALCIUM 534 360 101 11 8
POTASSIUM CHLORIDE 519 461 97 12 15
HYDROCODONE-ACETAMINOPHEN 485 386 143 S3 13 6
CLONIDINE HCL 388 338 66 14 42
CLOPIDOGREL 385 346 68 15 18
GABAPENTIN 381 304 69 16 11
ESCITALOPRAM OXALATE 326 273 50 17 53
NAMENDA 315 315 27 18 44
CITALOPRAM HBR 310 244 58 19 20
LISINOPRIL-HYDROCHLOROTHIAZIDE 296 191 52 20 38
TRAMADOL HCL 292 265 73 21 29
ATENOLOL 279 241 44 22 19
TAMSULOSIN HCL 274 213 50 23 30
EXELON 273 268* 38 24 121
LEVOFLOXACIN 267 211 200 25 68
LORAZEPAM 266 225 59 B 26 27
ALENDRONATE SODIUM 255 216 39 27 50
DONEPEZIL HCL 249 249 30 28 35
XARELTO 245 204 29 29 186
WARFARIN SODIUM 237 211 39 30 17
CARVEDILOL 228 223* 41 31 21
NEXIUM 225 206 36 32 28
PRAVASTATIN SODIUM 224 194 41 33 13
METOPROLOL SUCCINATE 213 193 40 34 26
LOVASTATIN 213 199 31 34 36
MIRTAZAPINE 205 200* 29 36 55
PROAIR HFA 200 111 63 37 40
CYMBALTA 197 181 23 38 47
JANUVIA 196 191* 23 39 76
LANTUS 193 143 48 40 64
PIOGLITAZONE HCL 190 163 19 R 41 108
DIOVAN 189 169 20 42 52
ZOLPIDEM TARTRATE 187 132 49 43 24
CRESTOR 179 149 33 44 34
ALLOPURINOL 157 133 27 45 31
SPIRIVA 155 125 32 46 56
LOSARTAN POTASSIUM 154 128 24 47 16
GEMFIBROZIL 149 86 24 48 95
TERAZOSIN HCL 147 124 24 49 132
LOSARTAN-HYDROCHLOROTHIAZIDE 142 123 22 50 45
DICLOFENAC POTASSIUM 134 89 41 51 297
PREDNISONE 127 105 76 52 48
EVISTA 123 108 15 53 147
IBUPROFEN 120 74 39 54 117
VALSARTAN-HYDROCHLOROTHIAZIDE 119 114* 21 55 87
GLYBURIDE 118 99 22 R 56 84
CLONAZEPAM 118 53 23 B 56 51
SYNTHROID 118 113* 22 56 57
GLIMEPIRIDE 118 93 21 56 32
ADVAIR DISKUS 118 91 29 56 67
ROPINIROLE HCL 118 86 18 56 85
LYRICA 118 67 16 56 80
CHLORTHALIDONE 115 103 18 63 126
LEVETIRACETAM 114 66 19 64 111
POLYETHYLENE GLYCOL 3350 112 99 38 65 81
ZETIA 111 97 14 66 77
FAMOTIDINE* 110 96 22 67 66
RISPERIDONE 102 86 20 A 68 86
ALBUTEROL SULFATE 101 86 36 69 166
SERTRALINE HCL 97 92* 18 70 22
ONDANSETRON HCL* 96 81 18 71 171
SPIRONOLACTONE 96 72 26 71 58
QUETIAPINE FUMARATE 96 91* 14 A 71 60
RANITIDINE HCL 95 90* 19 74 37
PROPRANOLOL HCL 95 90* 11 74 114
TRAZODONE HCL 92 77 19 76 39
LEVEMIR 91 73 17 77 137
TEMAZEPAM 91 70 18 B 77 100
VESICARE 90 <11 <11 79 133
FENOFIBRATE* 87 53 13 80 71
BENAZEPRIL HCL 86 65 15 81 46
PANTOPRAZOLE SODIUM 84 61 25 82 25
DIVALPROEX SODIUM 81 65 19 83 88
IPRATROPIUM-ALBUTEROL 76 <11 <11 84 143
PROMETHAZINE HCL 75 57 36 R 85 79
FINASTERIDE 74 74 16 86 109
AMOX TR-POTASSIUM CLAVULANATE 73 41 60 87 101
ISOSORBIDE MONONITRATE ER 71 <11 <11 88 65
FLUTICASONE PROPIONATE 71 33 25 88 33
JANTOVEN 70 65* 12 90 145
PHENYTOIN SODIUM EXTENDED 68 <11 <11 91 144
DOXYCYCLINE HYCLATE 67 62* 48 92 140
KLOR-CON M20 67 55 17 92 89
QUINAPRIL HCL 66 <11 <11 94 128
FLUOXETINE HCL 66 <11 <11 94 59
KLOR-CON 10 65 52 15 96 82
AMLODIPINE BESYLATE-BENAZEPRIL 64 <11 <11 97 74
RAMIPRIL 63 58* 14 98 78
METOCLOPRAMIDE HCL 62 47 11 99 131
HUMALOG 61 41 24 100 135
HYDROXYZINE HCL 61 45 13 R 100 179
PREMARIN 58 <11 <11 R 102 127
CARBIDOPA-LEVODOPA 58 <11 <11 102 125
BUSPIRONE HCL 57 <11 <11 104 107
VYTORIN 56 <11 <11 105 204
NIFEDIPINE ER 55 <11 <11 106 92
NAPROXEN 55 <11 <11 106 124
OLANZAPINE 54 49* 12 A 108 150
AMITRIPTYLINE HCL 53 <11 <11 R 109 69
DOXAZOSIN MESYLATE 52 <11 <11 110 104
CEFTRIAXONE* 51 46* 41 111 225
DIGOX 51 46* 11 111 96
NOVOLIN R 51 <11 <11 111 196
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 24, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.